Lannett Company Inc (NYSE:LCI)
| 0.6475 Delayed Data As of 3:59pm ET |  0.00 / 0.00%Today’s Change | 0.39 Today|||52-Week Range 1.01 | +24.33% Year-to-Date |
Latest LCI News | Press Releases
| Lannett (LCI) Reports Q2 Loss, Tops Revenue Estimates Feb 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.65 |
| Today’s open | 0.68 |
| Day’s range | 0.60 - 0.68 |
| Volume | 210,868 |
| Average volume (3 months) | 228,589 |
| Market cap | $28.5M |
Data as of 3:59pm ET, 02/06/2023
Growth & Valuation
| Earnings growth (last year) | +37.79% |
| Earnings growth (this year) | -2.98% |
| Earnings growth (next 5 years) | -3.60% |
| Revenue growth (last year) | -28.86% |
| P/E ratio | NM |
| Price/Sales | 0.07 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LUMOLumos Pharma Inc | -0.05 | -1.44% |
| ---- | ||
| ZYNEZynerba Pharmaceutic... | -0.02 | -3.21% |
| CYCNCyclerion Therapeuti... | 0.00 | 0.00% |
Data as of 3:59pm ET, 02/06/2023
Financials
| Next reporting date | May 3, 2023 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $340.6M |
| Annual profit (last year) | -$231.6M |
| Net profit margin | -68.01% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Trevose, Pennsylvania |
Forecasts
